The New Leviathan: A National Disability Insurance Scheme

Andrew BakerNovember 15, 2012PM131

The National Disability Insurance Scheme (NDIS) has been touted as the biggest and most expensive social reform since Medicare. The Productivity Commission initially estimated that the NDIS would provide disability care and support services to 411,000 people at a cost of $13.5 billion (gross) every year. However, subsequent estimates have revised the cost of the scheme to more than $22 billion (gross) every year when the scheme is fully operational in 2018–19. This report argues that this figure does not adequately reflect the ongoing cost of the NDIS in first few years following full implementation. Based on case studies of similar schemes in Australia and overseas, it is clear that the government expenditure on the NDIS will grow rapidly, at around 6% every year; by 2023–24, the NDIS will provide disability care and support services to around 500,000 people at a cost of approximately $29 billion (gross). This report also outlines a number of risks to the scheme that have the potential to drive expenditure on the scheme even higher. The NDIS will be the new leviathan of the Australian welfare state.

Andrew Baker is a Policy Analyst at The Centre for Independent Studies.

 

Related Commentary

The mental health system may be making us sicker
Steven SchwartzApril 6, 2026CANBERRA TIMES

Australia has a mental health crisis, but not the one we think. Despite decades of...

Housing negative gearing tax
Reducing the discount would likely not have any lasting impact in lowering house prices
Robert Carling, Michael StutchburyMarch 21, 2026CANBERRA TIMES

Anyone watching the smoke signals from Canberra knows that moves are afoot to try and...

Alarm bells ringing on more interest rate pain
Michael StutchburyMarch 18, 2026DAILY TELEGRAPH
Australians were losing faith that the combination of Labor’s economic policies and the RBA monetary...

• Subscribe

Subscribe now and stay in the loop with our giving appeals, event alerts, newsletters and research updates.

We are always pleased to hear from you. If you have any questions or feedback, please contact us here: